Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

US Patent 9822118 · Granted Nov 21, 2017

Estimated economic value: $29,977,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2025
Heterocyclic compounds and their use for treatment of helminthic infections and 2025
Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fl2025
FGFR3 inhibitor compounds2025
FGFR3 inhibitor compounds2025
Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fl2024
Antiproliferative compounds and methods of use thereof2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
RET kinase inhibitors2024
Compounds useful for inhibiting RET kinase2024
KRas G12D inhibitors2024
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and me2024